###begin article-title 0
MTHFR C677T and postmenopausal breast cancer risk by intakes of one-carbon metabolism nutrients: a nested case-control study
###end article-title 0
###begin title 1
Introduction
###end title 1
###begin p 2
###xml 67 72 67 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 345 351 345 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR </italic>
###xml 494 495 494 495 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 498 499 498 499 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 506 508 506 508 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
The C677T polymorphism of the methylenetetrahydrofolate reductase (MTHFR) gene has been hypothesized to increase breast cancer risk. However, results have been inconsistent, and few studies have reported the association by menopausal status or by intakes of nutrients participating in one-carbon metabolism. Our aims were to investigate whether MTHFR C677T was associated with postmenopausal breast cancer risk and whether this relation was modified by intakes of folate, methionine, vitamins B2, B6, and B12, and alcohol.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 231 237 231 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR </italic>
###xml 146 151 <span type="species:ncbi:9606">women</span>
We studied 318 incident breast cancer cases and 647 age- and race-matched controls participating in a nested case-control study of postmenopausal women within the VITamins And Lifestyle (VITAL) cohort. Genotyping was conducted for MTHFR C677T and dietary and supplemental intakes were ascertained from a validated questionnaire. Adjusted odds ratios (OR) and 95% confidence intervals (CI) were calculated using unconditional logistic regression.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 215 217 215 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 427 429 427 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 497 499 497 499 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6 </sub>
###xml 500 502 500 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 71 76 <span type="species:ncbi:9606">women</span>
###xml 133 138 <span type="species:ncbi:9606">Women</span>
###xml 378 383 <span type="species:ncbi:9606">women</span>
###xml 569 574 <span type="species:ncbi:9606">women</span>
We observed a 62% increased risk of breast cancer among postmenopausal women with the TT genotype (OR = 1.62; 95% CI: 1.05 to 2.48). Women with a higher number of variant T alleles had higher risk of breast cancer (P for trend = 0.04). Evidence of effect-modification by intakes of some B vitamins was observed. The most pronounced MTHFR-breast cancer risks were observed among women with the lowest intakes of dietary folate (P for interaction = 0.02) and total (diet plus supplemental) vitamin B6 (P for interaction = 0.01), with no significant increased risks among women with higher intakes.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
###xml 37 43 37 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR </italic>
This study provides support that the MTHFR 677TT genotype is associated with a moderate increase in risk of postmenopausal breast cancer and that this risk may be attenuated with high intakes of some one-carbon associated nutrients.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 541 547 541 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR </italic>
###xml 661 662 661 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 818 819 818 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 820 821 820 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
Methylenetetrahydrofolate reductase (MTHFR) catalyzes the irreversible reduction of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, the primary circulating form of folate and methyl donor in DNA methylation. MTHFR is a critical enzyme in one-carbon metabolism, redirecting the pool of folate from DNA synthesis/repair to methylation. It is of interest because aberrations in DNA synthesis, repair, and methylation, have been implicated with cancer risk. The substitution of cytosine (C) with thymine (T) at nucleotide 677 in the MTHFR gene is a common polymorphism (C677T) and is correlated with increased thermolability and reduced MTHFR activity [1]. Homozygotes (677TT) have approximately 30% and heterozygotes (677CT) have approximately 65% the activity of homozygous wild-types (677CC), respectively [1,2].
###end p 10
###begin p 11
###xml 146 152 146 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR </italic>
###xml 202 203 202 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 204 205 204 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 453 454 453 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 455 456 455 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 620 621 620 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 622 623 622 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
The C677T polymorphism has been studied extensively, yet for breast cancer risk, three recent meta-analyses suggest that the association with the MTHFR C677T polymorphism has been largely inconsistent [3-5]. Several reviews suggest that for breast cancer, the relation may vary by menopausal status and also, highlight the importance of examining potential effect of risk modification by nutrients that contribute to or interrupt one-carbon metabolism [3,4]. However, few studies have reported estimates by menopausal status, and most have not examined additional nutrient effect modifiers other than folate or alcohol [3-5]. A further limitation among investigations examining dietary effect modifiers is that most have utilized diet recalled after cancer diagnosis which has the potential for recall bias.
###end p 11
###begin p 12
###xml 57 63 57 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR </italic>
###xml 377 378 377 378 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 381 382 381 382 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 389 393 389 393 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12, </sub>
###xml 524 525 524 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 126 131 <span type="species:ncbi:9606">women</span>
We, therefore, investigated the relationship between the MTHFR C677T polymorphism and breast cancer risk among postmenopausal women in a nested case-control study within the VITamins And Lifestyle (VITAL) cohort. We also examined whether this relation was modified by prediagnostic intakes of nutrients involved in one-carbon metabolism (that is, folate, methionine, vitamins B2, B6, and B12, and alcohol). Previously, in the VITAL cohort, we observed a protective association between folate intakes and breast cancer risk [6].
###end p 12
###begin title 13
Materials and methods
###end title 13
###begin title 14
VITAL cohort
###end title 14
###begin p 15
###xml 128 129 128 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 141 144 <span type="species:ncbi:9606">men</span>
###xml 149 154 <span type="species:ncbi:9606">women</span>
###xml 402 414 <span type="species:ncbi:9606">participants</span>
###xml 538 543 <span type="species:ncbi:9606">women</span>
The VITAL cohort was principally designed to investigate supplement use and cancer risk. Details have been previously reported [7]. Briefly, men and women were eligible to join the VITAL cohort if they aged 50 and 76 years and living in the western area of Washington State covered by the Surveillance, Epidemiology, and End Results (SEER) cancer registry. A 24-page baseline questionnaire was sent to participants, using names from a commercial mailing list. Data collection occurred from October 2000 to December 2002. Among the 40,339 women who were eligible, 25.6% responded to the baseline questionnaire.
###end p 15
###begin title 16
Selection of cases and controls
###end title 16
###begin p 17
###xml 629 634 629 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 754 761 754 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 130 138 <span type="species:ncbi:9606">patients</span>
###xml 209 214 <span type="species:ncbi:9606">women</span>
###xml 549 554 <span type="species:ncbi:9606">women</span>
###xml 592 597 <span type="species:ncbi:9606">women</span>
###xml 683 688 <span type="species:ncbi:9606">women</span>
Breast cancer cases were identified by linkage to the SEER cancer registry. From baseline to December 30, 2003, 514 breast cancer patients were identified. To form the nested case-control dataset, we excluded women who reported a history of breast cancer (n = 48), had rare breast histologies (that is, sarcoma, phyllodes, or lymphoma, n = 4), did not provide buccal cell samples needed for genotyping (n = 127), or did not complete the breast-cancer risk-factor page of the baseline questionnaire (n = 1), leaving 334 cases. We further excluded 12 women who were not postmenopausal and four women who failed to be genotyped for MTHFR. After these criteria, 318 postmenopausal VITAL women who had been diagnosed with incident breast cancer (invasive and in situ) remained.
###end p 17
###begin p 18
###xml 1313 1318 1313 1318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 14 19 <span type="species:ncbi:9606">women</span>
###xml 212 217 <span type="species:ncbi:9606">women</span>
Controls were women who were not diagnosed with any type of cancer since baseline (based on linkage to SEER) and had not reported a history of breast cancer on the baseline questionnaire. There were 36,096 VITAL women without a cancer diagnosis (any type of cancer) since baseline and had never been diagnosed with breast cancer. Of these possible controls, 11,798 were excluded because they did not provide a buccal cell sample, and 185 were excluded because the breast-cancer risk-factor page of the baseline questionnaire was not completed. Two controls for each case were randomly selected from the remaining 24,113 possible (pre- and postmenopausal) controls by frequency matching on age at baseline (in five-year intervals) and race resulting in 668 controls. We also ensured that the follow-up times of the controls (time from baseline to death, a move out of area, or December 31, 2003) were greater than or equal to the follow-up times of the cases (time from baseline to breast cancer diagnosis). Information on deaths and moves out of the area were obtained by linking the VITAL cohort to the Washington State death files and the National Change of Address system. For this current analysis, we excluded 19 controls who were not postmenopausal and two controls whose samples failed to be genotyped for MTHFR, leaving 647 postmenopausal controls. This study was approved by the Fred Hutchinson Cancer Research Center Institutional Review Board (IRB), Seattle, Washington. Voluntary return of the questionnaire was considered implied consent.
###end p 18
###begin title 19
Genotyping
###end title 19
###begin p 20
###xml 338 344 338 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR </italic>
###xml 545 546 545 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 63 68 <span type="species:ncbi:9606">Women</span>
DNA was obtained from buccal cells collected from cytobrushes. Women who completed the VITAL baseline questionnaire were mailed a DNA kit containing three sterile cytobrushes, detailed instructions with pictures for use of kit, and a consent form. Genotyping was done by InterGenetics Incorporated (Oklahoma City, OK, USA). Genotyping of MTHFR C677T was determined using a microsphere-based, allele-specific primer extension (ASPE) assay followed by analysis on the Luminex 100 flow cytometer (Luminex, Austin, TX, USA) as previously described [8]. DNA was amplified by multiplex PCR using HotStar Taq DNA polymerase (Qiagen Inc., Valencia, CA, USA). To ensure quality control, cases and controls were mixed on genotyping plates, and genotyping was performed with blinding to case-control status. To ensure there was no signal in wells without DNA added, each plate had at least three buffer blanks that were carried through the entire PCR/ASPE/Luminex process. Moreover, at least 5% of the samples were randomly selected and genotyped in duplicate with a concordance rate >99%.
###end p 20
###begin title 21
Effect modifiers and covariates
###end title 21
###begin p 22
###xml 216 221 <span type="species:ncbi:9606">Women</span>
###xml 450 455 <span type="species:ncbi:9606">women</span>
Information on diet, medical history, reproductive history, lifestyle factors, personal characteristics, and family history of breast cancer was collected at baseline using a 24-page self-administered questionnaire. Women were considered postmenopausal if they had a natural menopause with no periods in the year before baseline, had ever used postmenopausal hormones (PMH), had bilateral oophorectomy, or were 60 years or older at baseline. Because women with a hysterectomy without bilateral oophorectomy cannot report on menopause, they were considered to be postmenopausal if they had ever used hormone therapy or were 55 years or older at baseline.
###end p 22
###begin p 23
###xml 41 42 41 42 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 45 46 45 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 53 55 53 55 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 173 178 173 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 383 384 383 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 520 526 520 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">stress</italic>
###xml 767 769 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 338 343 <span type="species:ncbi:9606">Women</span>
###xml 390 402 <span type="species:ncbi:9606">Participants</span>
Intakes of folate, methionine, vitamins B2, B6, and B12, multivitamins and alcohol reported on the baseline questionnaire were examined as potential effect modifiers of the MTHFR-breast cancer relationship. Intakes from diet over the past year were determined from a semi-quantitative food frequency questionnaire (FFQ), adapted from the Women's Health Initiative and other studies [9-11]. Participants also reported intakes of multivitamins and individual vitamin supplements, taken singly or as mixtures (for example, stress/B-complex, antioxidant mixtures), including questions on years of use in the 10 years before baseline, days per week of use and dose per day. The validity and reliability of supplement reporting in this cohort has been previously examined [12].
###end p 23
###begin p 24
###xml 96 98 96 98 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 150 152 150 152 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 214 216 214 216 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 719 721 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
We analyzed B vitamins from diet, supplement and diet plus supplement (total) sources. Vitamin B2 was not asked as an individual supplement, so only B2 as a multivitamin was considered, and therefore supplemental B2 was not considered alone. Methionine was determined from diet only. Average daily intake of dietary nutrients was calculated from the FFQ by multiplying the adjusted serving frequency (calculated as frequency times portion size) of each food/beverage item by its nutrient content and summing the nutrient contributions of all foods or beverages. The nutrient database used, the Minnesota Nutrient Data System for Research (University of Minnesota's Nutrition Coordinating Center, Minneapolis, MN, USA) [13], took into account the U.S. mandated folic acid fortification of grain products. Total alcohol intakes were calculated from all reported past-year consumption of red wine, white wine, beer, and liquor/mixed drinks.
###end p 24
###begin p 25
###xml 126 127 126 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 653 684 652 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">one-carbon micronutrient score </italic>
###xml 765 766 764 765 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 769 770 768 769 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 773 776 772 775 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12 </sub>
###xml 1175 1176 1174 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 880 885 <span type="species:ncbi:9606">Women</span>
Intakes of supplemental folate, other micronutrients, and multivitamins were averaged over 10 years, as previously described [6]. We needed a conversion factor [14] for the calculation of total folate because synthetic folate (folic acid) is more bioavailable than naturally occurring folate (polyglutamates). Thus, total folate, expressed in dietary folate equivalents (DFE), was obtained by first multiplying synthetic folate (supplements and fortified in foods) by a conversion factor of 1.7 and then, adding intakes of natural food folate (mug). To summarize intakes of micronutrients that act as cofactors in the one-carbon pathway, we generated a one-carbon micronutrient score by summing the z-scores of total folate, dietary methionine, and total vitamins B2, B6, B12 and then, dividing this score into high (upper median) and low (lower median) for categorical analyses. Women were excluded from the dietary and total (diet plus supplement) nutrient analyses if they did not complete all pages the FFQ or if their reported total energy intake was <600 or >4,000 kcal. Breast cancer risk factors and demographic variables were reported on the baseline questionnaire [6].
###end p 25
###begin title 26
Statistical analyses
###end title 26
###begin p 27
###xml 234 236 234 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 531 536 531 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 599 605 599 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR </italic>
###xml 679 685 679 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR </italic>
We compared baseline characteristics of cases and controls using Wilcoxon signed-rank tests (for continuous variables) or Chi-square tests (for dichotomous variables). Observed genotype frequencies were in Hardy-Weinberg equilibrium (P > 0.05). Odds ratios (OR) for breast cancer risk and 95% confidence intervals (CI) were calculated using unconditional logistic regression adjusting for the matching factors of age at baseline (50 to 54 years, 55 to 59, 60 to 64, 65 to 69, 70 to 76) and race (white, other). For analyses of the MTHFR-breast cancer association, we assigned the wild-type genotype MTHFR 677CC as the reference group. Linear trend was calculated by modeling the MTHFR genotype (CC, CT, and TT) as one term, ordinally.
###end p 27
###begin p 28
###xml 41 42 41 42 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 45 46 45 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 53 55 53 55 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 135 140 135 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 550 553 550 551 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 645 647 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1209 1215 1205 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR </italic>
###xml 1480 1486 1476 1482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR </italic>
###xml 1598 1599 1594 1595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1708 1710 1704 1706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 706 711 <span type="species:ncbi:9606">women</span>
###xml 1194 1199 <span type="species:ncbi:9606">women</span>
Intakes of folate, methionine, vitamins B2, B6, and B12, multivitamins, and alcohol were examined as potential effect modifiers of the MTHFR-breast cancer relationship. We dichotomized dietary and total intakes of the B vitamins and methionine by median intakes. Multivitamin intake was divided into some and no intake over the 10 years prior to baseline, and B vitamin consumption from supplements (that is, individual vitamins plus multivitamins) were dichotomized by levels at or above the dose obtained by 10 year daily use of a standard (Centrum(R)) multivitamin versus below that level. Based on previous literature on breast cancer risk [15], and the distribution of alcohol consumption among VITAL women, alcohol was dichotomized into <10 g/d and >/= 10 g/d intakes (that is, approximately one drink/day). Categorizations of all nutrients were based according to the distribution of intakes among controls. For our examination of effect modification, odds ratios were adjusted for the matching factors of age and race in addition to following standard breast cancer risk factors, as described in the footnote of the last table. To best illustrate the joint effects, we cross-classified women by their MTHFR genotype and the dichotomous effect modifier and used a single reference group for the odds ratios. The group hypothesized to have the lowest risk was selected as the reference group. Tests for interaction were performed by entering the product term of the ordinal MTHFR variable and dichotomous effect modifier in a multivariable-adjusted model and using Wald statistic to obtain a P-value. All statistical analyses were performed using SAS, version 9.1, (SAS Institute Inc., Cary, NC, USA). P values < 0.05 were considered statistically significant and all statistical tests were two-sided.
###end p 28
###begin title 29
Results
###end title 29
###begin p 30
###xml 73 74 73 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 522 528 522 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR </italic>
###xml 0 12 <span type="species:ncbi:9606">Participants</span>
Participants were on average 64 years of age and mostly Caucasian (Table 1). As expected, cases were significantly more likely than controls to have breast cancer risk factors such as having a prior breast biopsy, having fewer births, using PMH, and drinking more alcohol. Additionally, although not statistically significant, more cases than controls had a first-degree family history, young age at menarche, and were nulliparous. The majority of breast tumors were invasive (n = 253). Among controls, the frequencies of MTHFR genotypes were: 677CC (46.5%), 677CT (43.9%), and 677TT (9.6%).
###end p 30
###begin p 31
Characteristics of postmenopausal breast cancer cases and controls, VITAL study *
###end p 31
###begin p 32
###xml 176 182 176 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR </italic>
###xml 127 132 <span type="species:ncbi:9606">women</span>
* Cases and controls were originally 2:1 matched on age and race; the number of cases and controls are not exactly 2:1 because women who were premenopausal or who did not have MTHFR genotype data were excluded.
###end p 32
###begin p 33
daggerWilcoxon rank-sum test for continuous variables and chi-square test for dichotomous variables
###end p 33
###begin p 34
###xml 26 31 <span type="species:ncbi:9606">women</span>
double daggerAmong parous women only
###end p 34
###begin p 35
section signIntake from dietary plus supplemental sources
###end p 35
###begin p 36
###xml 30 36 30 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR </italic>
###xml 162 163 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 270 272 270 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 352 358 352 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR </italic>
###xml 414 415 414 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 467 473 467 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR </italic>
###xml 15 20 <span type="species:ncbi:9606">women</span>
Postmenopausal women with the MTHFR 677TT genotype had significantly higher risk of breast cancer (0R = 1.62; 95% CI: 1.05 to 2.48) than 677CC individuals (Table 2). The test for increasing breast cancer risk with increasing number of variant T alleles was significant (P for trend = 0.04), although there was no clear excess risk for the heterozygous MTHFR 677CT genotype (OR = 1.08; 95% CI: 0.81 to 1.43) (Table 2). We observed an increased breast cancer risk with MTHFR 677TT even after restricting to invasive breast cancer cases (RR = 1.65; 95% CI: 1.03 to 2.63) and when restricting to Caucasians (RR = 1.59; 95% CI: 1.03 to 2.46 for 302 cases) (data not shown).
###end p 36
###begin p 37
###xml 53 59 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR </italic>
Odds ratios (OR) for postmenopausal breast cancer by MTHFR C677T genotype, VITAL study
###end p 37
###begin p 38
* Adjusted for age in five year-age categories and race (white, other).
###end p 38
###begin p 39
###xml 7 9 2 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 47 52 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
dagger P for trend calculated by modelling the MTHFR. genotypes CC, CT, and TT as one term, ordinally.
###end p 39
###begin p 40
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 139 140 139 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 641 642 641 642 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 645 646 645 646 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 653 656 653 656 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12 </sub>
###xml 847 853 847 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR </italic>
###xml 941 943 941 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 978 980 978 980 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6 </sub>
###xml 981 983 981 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 1066 1068 1066 1068 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6 </sub>
###xml 1119 1121 1119 1121 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6 </sub>
###xml 1206 1208 1206 1208 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6 </sub>
###xml 1381 1383 1381 1383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 832 837 <span type="species:ncbi:9606">women</span>
###xml 899 904 <span type="species:ncbi:9606">women</span>
###xml 1102 1107 <span type="species:ncbi:9606">women</span>
###xml 1190 1195 <span type="species:ncbi:9606">women</span>
###xml 1422 1427 <span type="species:ncbi:9606">women</span>
We next examined whether the MTHFR-breast cancer association was modified by intakes of nutrients involved in one-carbon metabolism (Table 3). In general, elevated risks of breast cancer were observed among individuals with the 677TT genotype in the lower nutrient intake groups, and statistically significant trends with genotype were seen in these groups. Furthermore, odds ratios appeared stronger among groups defined by low intake of nutrients from total sources than from diet or supplements alone. The similarity of these results across nutrients is due, in part, to the high correlation between intakes of total folate and vitamins B2, B6, and B12 (range of correlations between nutrients (r): 0.60 to 0.79). However, only two of these results showed a statistically significant interaction: the risk of breast cancer among women with the MTHFR 677TT genotype was significantly higher among women with low intakes of dietary folate (P for interaction = 0.02) and total B6 (P for interaction = 0.01) than those with higher intakes. Results for total vitamin B6 were particularly striking. Among women with high B6 intake, there was no MTHFR-breast cancer association. However, among women with low B6 intake, the TT genotype was associated with an approximate four-fold risk (OR = 4.03 = 4.47/1.11). Alcohol intake did not appear to modify the exposure-disease association (P for interaction = 0.22), but few VITAL women drank >/= 10 g/d of alcohol.
###end p 40
###begin p 41
###xml 21 27 21 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR </italic>
Joint association of MTHFR C677T genotype and nutrient intakes on postmenopausal breast cancer risk, VITAL study *,dagger
###end p 41
###begin p 42
###xml 649 650 631 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
* All analyses adjusted for the following:age (50-54 years, 55-59, 60-64, 65-69, 70-76), race (white, other), family history of breast cancer (no, 1 affected mother or sister, >/= 2 affected mother or sister(s)), mammography within two years preceding baseline(no, yes), history of breast biopsy (no, yes), age at menarche (</= 11 years,12,13, >/= 14), age at first birth (nulliparous, </= 19 years, 20-24, 25-34, >/= 35), age at menopause (</= 44 years,45-49, >/= 50), years of combined estrogen and progestin postmenopausal hormones (PMH, never or <1 years,1-4,5-9, >/= 10), height (<62 in, 62-<65, 65-<68, >/= 68), body mass index (BMI) (<25 kg/m2,25-<30, >/= 30), total physical activity (none, 1-3 tertiles of MET-hours/week), total energy intake (kcal/day), and for non-alcohol exposures, past-year alcohol intake (<1.5 g/day, 1.5-4.9, 5.0-9.9, >/= 10). Energy was added to the models for all dietary and total nutrient exposures.
###end p 42
###begin p 43
dagger Case/control numbers do not add up to total due to missing data on nutrient intakes
###end p 43
###begin p 44
###xml 44 50 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR </italic>
###xml 130 136 118 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR </italic>
double dagger P for trend testing trend for MTHFR genotypes by strata of nutrient/alcohol intakes and calculated by modelling the MTHFR genotypes (CC, CT, and TT) as one term, ordinally
###end p 44
###begin p 45
###xml 70 76 59 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR </italic>
section signP for interaction testing whether the association between MTHFR and breast cancer varies by nutrient/alcohol intake
###end p 45
###begin p 46
Median intakes, based on distribution of nutrient intake from controls
###end p 46
###begin p 47
# Intakes of all supplements over 10 years; cutpoints represent amount in a 10 year daily use of standard multivitamin or greater
###end p 47
###begin p 48
###xml 93 94 93 94 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 97 98 97 98 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 101 104 101 104 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12 </sub>
** Micronutrient score computed by summing the z-scores of folate, methionine, and vitamins B2, B6, B12 and then, dividing this sum into high (upper median) and low (lower median) groups.
###end p 48
###begin title 49
Discussion
###end title 49
###begin p 50
###xml 270 271 270 271 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 121 126 <span type="species:ncbi:9606">women</span>
In this moderate-sized, nested case-control study, we observed a 62% increase risk of breast cancer among postmenopausal women with the TT genotype. The most pronounced risks were observed among individuals with the TT genotype and lowest intakes of folate and vitamin B6.
###end p 50
###begin p 51
###xml 38 39 38 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 40 42 40 42 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 43 45 43 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 61 67 61 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR </italic>
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 630 632 630 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 697 699 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 700 702 700 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 703 705 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 706 708 706 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 709 711 709 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 715 717 715 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 855 857 855 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 858 860 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 861 863 861 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 879 881 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 882 884 882 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 1334 1335 1334 1335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 1336 1338 1336 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 1339 1341 1339 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 1342 1344 1342 1344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 1345 1347 1345 1347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 1348 1350 1348 1350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 1351 1353 1351 1353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 1354 1356 1354 1356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 251 256 <span type="species:ncbi:9606">women</span>
###xml 351 356 <span type="species:ncbi:9606">women</span>
###xml 487 493 <span type="species:ncbi:8164">Suzuki</span>
###xml 580 585 <span type="species:ncbi:9606">women</span>
###xml 690 695 <span type="species:ncbi:9606">women</span>
###xml 967 972 <span type="species:ncbi:9606">women</span>
###xml 1496 1504 <span type="species:ncbi:9606">patients</span>
Results from 26 case-control studies [4,16-40] investigating MTHFR C677T and breast cancer risk have been inconsistent. Our results are consistent with two [18,19] of nine studies [17-20,22,26,27,29,31] reporting separate estimates for postmenopausal women. Ericson et al observed a significant 34% increase in breast cancer risk among postmenopausal women in Sweden with CT and TT genotypes compared to wild-type in a nested case-control study of the Malmo Diet and Cancer cohort [19]. Suzuki reported a significant 83% increased breast cancer risk among postmenopausal Japanese women with the TT genotype compared to wild-type [18]. Among 10 studies reporting estimates for premenopausal women [16-19,22,26,27,29-31], three have reported significant positive associations, ranging from a 64% to a 2.8-fold increased risk among CT and/or TT individuals [16,17,30]. Two studies [23,32] observed statistically significant increased risks among pre- and postmenopausal women combined. Other investigations have not reported significant associations. Differences in results may be due to variation between populations with regards to prevalence of polymorphisms in genes related to one-carbon metabolism, intakes of nutrients, and/or risk factors for breast cancer. Several studies reporting no association had <150 breast cancer cases [4,24,25,33,34,36,37,39], and thus, may have been too small to detect an association. Our study tended to have a larger population of postmenopausal breast cancer patients, and thus, may have had more power to detect an effect.
###end p 51
###begin p 52
###xml 59 65 59 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR </italic>
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 727 729 727 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 730 732 730 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 733 735 733 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 168 173 <span type="species:ncbi:9606">women</span>
Eight studies, to-date, have examined interactions between MTHFR C677T and nutrients, including alcohol [17-23,25]. Among these, only a case-control study of Brazilian women (458 age-matched pairs) observed statistically significant gene-diet interactions [22]. However, the folate results were opposite than expected; a significantly reduced risk of breast cancer was observed among TT and CT individuals with the lowest intakes of dietary folate. Major limitations were that diet was collected after breast cancer diagnosis and recall of diet was poor. While the tests of interaction were not significant, three studies observed increased MTHFR-breast cancer risks with low folate intakes which are in line with our results [18,21,23].
###end p 52
###begin p 53
###xml 123 124 123 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 125 126 125 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 499 501 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 830 832 830 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 833 835 833 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 1085 1087 1085 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 1088 1090 1088 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 1193 1194 1193 1194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 1443 1445 1443 1445 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6 </sub>
###xml 1721 1723 1721 1723 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6 </sub>
###xml 1766 1767 1766 1767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
Our results are biologically plausible. The TT genotype is associated with approximately 65% less activity than wild-type [1,2]. Reduced MTHFR activity among 677TT individuals may increase cancer risk by leading to lowered availability of 5-methyltetrahydrofolate and subsequently, impaired DNA methylation. DNA methylation plays a critical role in gene expression and the maintenance of genomic stability [41,42], and dysregulation of methylation patterns have been implicated with carcinogenesis [43,44]. Furthermore, our results suggest a more pronounced risk of breast cancer among 677TT individuals when intakes of nutrients associated with one-carbon metabolism are comparatively low. This finding is consistent with multiple studies showing increases in risk of colorectal adenomas or cancer under a low one-carbon status [45,46]. Furthermore, our results are supported by other reports suggesting that when folate levels are low, the 677TT genotype is associated with higher levels of homocysteine, lower levels of methylated folate, and reductions in genomic DNA methylation [47,48]. Our previous study in VITAL and other reports suggest that folate intake lowers breast cancer risk [6]. Reasons for not being able to replicate the earlier VITAL cohort findings may be that this nested case-control study had approximately three-years shorter follow-up and fewer cases (334 versus 743 cases in the cohort study publication). Vitamin B6 has an important role in one-carbon metabolism in that it acts as a cofactor for methionine synthesis and is a coenzyme of serine hydroxymethyltransferase, which is involved in nucleotide synthesis. We did not observe an overall statistically significant association between B6 intake and breast cancer risk, previously [6]. However, it is possible that intakes below a certain threshold may make 677TT individuals more susceptible.
###end p 53
###begin p 54
###xml 69 75 69 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR </italic>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
Our study has some limitations. First, we did not have data on other MTHFR polymorphisms, such as A1298C and G1793A. However, data suggest that C677T is the major genetic determinant of MTHFR activity [49]. Second, the high correlation between nutrient intakes (r >/= 0.60) made it difficult to separately examine effect modification of individual nutrients. Lastly, nutrient and supplement intakes were based on self-report; however, because this information was collected prior to diagnosis, any misclassification would have been non-differential and would most likely have attenuated the associations. Another source of measurement error, apart from inaccuracies in self-report, is that the folate content of food changed over time. Food manufacturers began fortifying grain products starting in 1996 to 1998 in response to U.S. governmental regulations, a few years before the VITAL baseline questionnaire (2000 to 2002). Thus, the high levels of intake in this population represent the post-fortification period, while intake earlier during the pre-fortification period may be more predictive of breast cancer risk. Since low folate intake is of most interest in MTHR effect modification, use of post-fortification folate values may have weakened our ability to detect effect modification by low folate intakes.
###end p 54
###begin p 55
###xml 110 116 110 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR </italic>
###xml 353 359 353 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR </italic>
###xml 380 385 <span type="species:ncbi:9606">women</span>
###xml 683 695 <span type="species:ncbi:9606">participants</span>
Our study adds to the literature by being the first study, to our knowledge, examining effect modification of MTHFR by multiple nutrients involved in the one-carbon metabolism pathway; data on supplement use also allowed for analysis by nutrient type (diet, supplement, and total). This study also adds to current knowledge regarding the association of MTHFR among postmenopausal women. An advantage of this study's prospective design is that it avoids recall bias for the recall of nutrients. An additional strength is that we had a broad range of information on possible confounders for adjustment. Also, selection bias is highly unlikely, because this was a prospective study and participants would not have known their future breast cancer status when deciding to give buccal cells or complete the breast cancer risk questions.
###end p 55
###begin title 56
Conclusions
###end title 56
###begin p 57
###xml 49 55 49 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR </italic>
###xml 233 234 233 234 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 187 192 <span type="species:ncbi:9606">women</span>
In summary, this study provides support that the MTHFR 677TT genotype is associated with a moderately increased risk of postmenopausal breast cancer and with a substantial increase among women with low intakes of folate and vitamin B6. From a public health standpoint, these results are of interest in that they suggest that the increased risk associated with the TT genotype may be attenuated with intakes of some one-carbon associated nutrients.
###end p 57
###begin title 58
Abbreviations
###end title 58
###begin p 59
ASPE: allele-specific primer extension; BMI: body mass index; CI: confidence interval; DNA: deoxyribonucleic acid; FFQ: food frequency questionnaire; IRB: Institutional Review Board; kcal: kilocalorie; MET: metabolic equivalent; MTHFR: methylenetetrahydrofolate reductase; PMH: postmenopausal hormones; OR: odds ratio; PCR: polymerase chain reaction; SD: standard deviation; SEER: Surveillance, Epidemiology, and End Results; VITAL: VITamins And Lifestyle.
###end p 59
###begin title 60
Competing interests
###end title 60
###begin p 61
ERJ is a salaried employee of and holds stock options in InterGenetics Incorporated, but is not a major shareholder. A grant from InterGenetics Incorporated provided partial support for genotyping analyses. The other authors declare that they have no competing interests.
###end p 61
###begin title 62
Authors' contributions
###end title 62
###begin p 63
SSM planned the data analysis, carried out all statistical analyses, interpreted the results, and drafted the manuscript. CMU contributed to the interpretation of the data and revised the manuscript for important intellectual content. ERJ directed the DNA isolation and the acquisition and finalization of the genotyping studies and revised the manuscript. EW conceived of the VITAL study, obtained funding, participated in the study's design and coordination, contributed to the interpretation of results, and revised the manuscript for important intellectual content. All authors read and approved the final manuscript.
###end p 63
###begin title 64
Acknowledgements
###end title 64
###begin p 65
###xml 343 355 <span type="species:ncbi:9606">participants</span>
The study was funded by the National Cancer Institute (NCI grants R01 CA74846 and R25 CA94880). A grant from InterGenetics Incorporated provided partial support for genotyping analyses. The manuscript is the sole responsibility of the authors and does not necessarily reflect the official views of the funding agencies. We are indebted to the participants of VITAL. We also thank the field and office staff at Fred Hutchinson Cancer Center for collecting and managing the data.
###end p 65
###begin article-title 66
A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase
###end article-title 66
###begin article-title 67
The 1298A-->C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine
###end article-title 67
###begin article-title 68
Methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a meta-analysis
###end article-title 68
###begin article-title 69
Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis
###end article-title 69
###begin article-title 70
Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk
###end article-title 70
###begin article-title 71
Folate and one-carbon metabolism nutrients from supplements and diet in relation to breast cancer risk
###end article-title 71
###begin article-title 72
VITamins And Lifestyle cohort study: study design and characteristics of supplement users
###end article-title 72
###begin article-title 73
Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer
###end article-title 73
###begin article-title 74
Measurement error from assessing use of vitamin supplements at one point in time
###end article-title 74
###begin article-title 75
###xml 141 146 <span type="species:ncbi:9606">Women</span>
Associations of race/ethnicity, education, and dietary intervention with the validity and reliability of a food frequency questionnaire: the Women's Health Trial Feasibility Study in Minority Populations
###end article-title 75
###begin article-title 76
###xml 35 40 <span type="species:ncbi:9606">Women</span>
Measurement characteristics of the Women's Health Initiative food frequency questionnaire
###end article-title 76
###begin article-title 77
Reliability and validity of self-report of vitamin and mineral supplement use in the vitamins and lifestyle study
###end article-title 77
###begin article-title 78
Procedures for estimating nutrient values for food composition databases
###end article-title 78
###begin article-title 79
###xml 29 34 <span type="species:ncbi:9606">women</span>
Alcohol and breast cancer in women: a pooled analysis of cohort studies
###end article-title 79
###begin article-title 80
Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer
###end article-title 80
###begin article-title 81
Breast cancer risk and methylenetetrahydrofolate reductase polymorphism
###end article-title 81
###begin article-title 82
One-carbon metabolism-related gene polymorphisms and risk of breast cancer
###end article-title 82
###begin article-title 83
###xml 92 97 <span type="species:ncbi:9606">women</span>
Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmo Diet and Cancer cohort
###end article-title 83
###begin article-title 84
Association of polymorphisms in one-carbon metabolism genes and postmenopausal breast cancer incidence
###end article-title 84
###begin article-title 85
MTHFR polymorphisms, dietary folate intake, and breast cancer risk: results from the Shanghai Breast Cancer Study
###end article-title 85
###begin article-title 86
###xml 157 162 <span type="species:ncbi:9606">women</span>
Dietary intake of folate, vitamin B6, and vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Brazilian women
###end article-title 86
###begin article-title 87
One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer
###end article-title 87
###begin article-title 88
Reduced breast cancer risk with increasing serum folate in a case-control study of the C677T genotype of the methylenetetrahydrofolate reductase gene
###end article-title 88
###begin article-title 89
Folate and breast cancer: the role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR)
###end article-title 89
###begin article-title 90
Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancer
###end article-title 90
###begin article-title 91
MTHFR polymorphisms, diet, HRT, and breast cancer risk: the multiethnic cohort study
###end article-title 91
###begin article-title 92
The common 677C>T gene polymorphism of methylenetetrahydrofolate reductase gene is not associated with breast cancer risk
###end article-title 92
###begin article-title 93
One-carbon metabolism and breast cancer risk: no association of MTHFR, MTR, and TYMS polymorphisms in the GENICA study from Germany
###end article-title 93
###begin article-title 94
Polymorphisms in the MTHFR gene are associated with breast cancer
###end article-title 94
###begin article-title 95
###xml 84 89 <span type="species:ncbi:9606">women</span>
Methylenetetrahydrofolate reductase polymorphism, diet, and breast cancer in Korean women
###end article-title 95
###begin article-title 96
Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks
###end article-title 96
###begin article-title 97
No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer
###end article-title 97
###begin article-title 98
The association of p53 mutations and p53 codon 72, Her 2 codon 655 and MTHFR C677T polymorphisms with breast cancer in Northern Greece
###end article-title 98
###begin article-title 99
Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan
###end article-title 99
###begin article-title 100
Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis
###end article-title 100
###begin article-title 101
The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study
###end article-title 101
###begin article-title 102
Green tea intake, MTHFR/TYMS genotype and breast cancer risk: the Singapore Chinese Health Study
###end article-title 102
###begin article-title 103
Breast cancer risk associated with multigenotypic polymorphisms in folate-metabolizing genes: a nested case-control study in Taiwan
###end article-title 103
###begin article-title 104
###xml 105 110 <span type="species:ncbi:9606">women</span>
Polymorphism of cytosolic serine hydroxymethyltransferase, estrogen and breast cancer risk among Chinese women in Taiwan
###end article-title 104
###begin article-title 105
CpG islands in chromatin organization and gene expression
###end article-title 105
###begin article-title 106
DNA methylation and genetic instability in colorectal cancer cells
###end article-title 106
###begin article-title 107
The fundamental role of epigenetic events in cancer
###end article-title 107
###begin article-title 108
The relationship between hypomethylation and CpG island methylation in colorectal neoplasia
###end article-title 108
###begin article-title 109
Nutrigenetics in cancer research--folate metabolism and colorectal cancer
###end article-title 109
###begin article-title 110
Colorectal adenomas and the C677T MTHFR polymorphism: evidence for gene-environment interaction?
###end article-title 110
###begin article-title 111
A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status
###end article-title 111
###begin article-title 112
Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations
###end article-title 112
###begin article-title 113
Functional inference of the methylenetetrahydrofolate reductase 677C > T and 1298A > C polymorphisms from a large-scale epidemiological study
###end article-title 113

